National Cancer Institute Thesaurus

Last uploaded: February 23, 2024
Preferred Name

Eprosartan

Synonyms

EPROSARTAN

Eprosartan

Definitions

A competitive and reversible angiotensin II receptor antagonist with anti-hypertensive property. Eprosartan blocks the binding of angiotensin II to the angiotensin (AT)1 receptor in vascular smooth muscle, thereby blocking the principal pressor action of angiotensin II on the renin-angiotensin system resulting in vascular dilatation. In addition, this agent blocks angiotensin II -induced stimulation of aldosterone synthesis and secretion by the adrenal cortex, cardiac contraction, renal resorption of sodium, activity of the sympathetic nervous system, and smooth muscle cell growth. Furthermore, eprosartan inhibits sympathetic norepinephrine production, thereby further reducing blood pressure.

ID

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C61749

CAS_Registry

133040-01-4

CHEBI_ID

CHEBI:4814

Chemical_Formula

C23H24N2O4S

code

C61749

Concept_In_Subset

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C173381

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C173383

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C63923

Contributing_Source

FDA

DEFINITION

A competitive and reversible angiotensin II receptor antagonist with anti-hypertensive property. Eprosartan blocks the binding of angiotensin II to the angiotensin (AT)1 receptor in vascular smooth muscle, thereby blocking the principal pressor action of angiotensin II on the renin-angiotensin system resulting in vascular dilatation. In addition, this agent blocks angiotensin II -induced stimulation of aldosterone synthesis and secretion by the adrenal cortex, cardiac contraction, renal resorption of sodium, activity of the sympathetic nervous system, and smooth muscle cell growth. Furthermore, eprosartan inhibits sympathetic norepinephrine production, thereby further reducing blood pressure.

FDA_UNII_Code

2KH13Z0S0Y

FULL_SYN

EPROSARTAN

Eprosartan

Has_Salt_Form

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C47515

label

Eprosartan

Legacy Concept Name

Eprosartan

Preferred_Name

Eprosartan

prefixIRI

Thesaurus:C61749

Semantic_Type

Pharmacologic Substance

UMLS_CUI

C0287041

subClassOf

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C66930

Delete Subject Author Type Created
No notes to display
Create mapping

Delete Mapping To Ontology Source
http://purl.bioontology.org/ontology/VANDF/4021199 VANDF LOOM
http://stirdf.jst.go.jp/id/200907077085100303 IOBC LOOM
http://purl.bioontology.org/ontology/SNOMEDCT/396044005 SNOMEDCT LOOM
http://www.co-ode.org/ontologies/galen#Eprosartan GALEN LOOM
http://purl.obolibrary.org/obo/CHEBI_4814 PDRO LOOM
http://purl.obolibrary.org/obo/CHEBI_4814 DINTO LOOM
http://purl.obolibrary.org/obo/CHEBI_4814 CHEBI LOOM
http://purl.obolibrary.org/obo/CHEBI_4814 BERO LOOM
http://purl.obolibrary.org/obo/CHEBI_4814 BIOMODELS LOOM
http://purl.obolibrary.org/obo/CHEBI_4814 DRON LOOM
http://purl.obolibrary.org/obo/CHEBI_4814 NIFSTD LOOM
http://purl.bioontology.org/ontology/RXNORM/83515 NLMVS LOOM
http://purl.bioontology.org/ontology/RXNORM/83515 RXNORM LOOM
http://sbmi.uth.tmc.edu/ontology/ochv#C0287041 OCHV LOOM
http://sbmi.uth.tmc.edu/ontology/ochv#27742 OCHV LOOM
http://purl.bioontology.org/ontology/NDDF/007065 NDDF LOOM
http://www.drugbank.ca/drugs/DB00876 FTC LOOM
http://purl.obolibrary.org/obo/NCIT_C61749 BERO LOOM
http://www.phoc.org.cn/pmo/class/PMO_00025463 PMAPP-PMO LOOM
http://www.semanticweb.org/admin/ontologies/2022/7/MIO:02628 MIO LOOM
http://purl.bioontology.org/ontology/ATC/C09CA02 ATC LOOM
http://purl.obolibrary.org/obo/XCO_0000721 XCO LOOM
http://purl.bioontology.org/ontology/MESH/C068373 MESH LOOM
http://phenomebrowser.net/ontologies/mesh/mesh.owl#C068373 RH-MESH LOOM
https://go.drugbank.com/drugs/DB00876 MDM LOOM
http://purl.jp/bio/4/id/200906028219765612 IOBC LOOM
http://purl.bioontology.org/ontology/NDFRT/N0000148645 NDFRT LOOM